{"entity":{"type":"insider","cik":"0001298246","url":"/insider/0001298246","json_url":"/insider/0001298246.json","name":"Herskowitz Neil","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":23,"first":"2005-04-28","last":"2025-12-30","span_basis":"filed_date"},"name_variants":[{"name":"Herskowitz Neil","source":"filing","n_filings":23,"first_seen":"2005-04-28","last_seen":"2025-12-30"}],"transactions":[{"id":4800550,"accession":"0001104659-25-125233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-125233","line_url":"/filing/0001104659-25-125233#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"MUSTANG BIO, INC.","issuer_ticker":"MBIO","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK, PAR VALUE $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":247.0,"shares_display":"247","price_per_share":0.962,"price_display":"0.96","price_state":"stated","total_value":237.614,"total_display":"237.61","total_whole":"238","shares_owned_after":145.0,"shares_owned_after_display":"145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-30","filed_date":"2025-12-30","scope":"insider"},{"id":2086393,"accession":"0001104659-24-125093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-125093","line_url":"/filing/0001104659-24-125093#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK, PAR VALUE $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23.0,"shares_display":"23","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":46.0,"total_display":"46.00","total_whole":"46","shares_owned_after":97.0,"shares_owned_after_display":"97","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-03","scope":"insider"},{"id":4457927,"accession":"0001104659-21-062774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-062774","line_url":"/filing/0001104659-21-062774#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":3.99,"price_display":"3.99","price_state":"stated","total_value":9975.0,"total_display":"9,975.00","total_whole":"9,975","shares_owned_after":134724.0,"shares_owned_after_display":"134,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-07","scope":"insider"},{"id":2339332,"accession":"0001104659-20-027510","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-027510","line_url":"/filing/0001104659-20-027510#line-2","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2400.0,"shares_display":"2,400","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":19680.0,"total_display":"19,680.00","total_whole":"19,680","shares_owned_after":122224.0,"shares_owned_after_display":"122,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-27","filed_date":"2020-03-02","scope":"insider"},{"id":2339324,"accession":"0001104659-20-027510","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-027510","line_url":"/filing/0001104659-20-027510#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":161.0,"shares_display":"161","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":1405.53,"total_display":"1,405.53","total_whole":"1,406","shares_owned_after":119824.0,"shares_owned_after_display":"119,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-03-02","scope":"insider"},{"id":2137508,"accession":"0001104659-20-024813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-024813","line_url":"/filing/0001104659-20-024813#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.31,"price_display":"9.31","price_state":"stated","total_value":93100.0,"total_display":"93,100.00","total_whole":"93,100","shares_owned_after":119663.0,"shares_owned_after_display":"119,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-25","filed_date":"2020-02-25","scope":"insider"},{"id":8060276,"accession":"0001144204-19-031499","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-031499","line_url":"/filing/0001144204-19-031499#line-2","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":11660.0,"total_display":"11,660.00","total_whole":"11,660","shares_owned_after":99663.0,"shares_owned_after_display":"99,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-18","filed_date":"2019-06-19","scope":"insider"},{"id":8060271,"accession":"0001144204-19-031499","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-031499","line_url":"/filing/0001144204-19-031499#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":5.88,"price_display":"5.88","price_state":"stated","total_value":17640.0,"total_display":"17,640.00","total_whole":"17,640","shares_owned_after":97663.0,"shares_owned_after_display":"97,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2019-06-19","scope":"insider"},{"id":8386014,"accession":"0001144204-19-019691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-019691","line_url":"/filing/0001144204-19-019691#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.52,"price_display":"4.52","price_state":"stated","total_value":4520.0,"total_display":"4,520.00","total_whole":"4,520","shares_owned_after":94663.0,"shares_owned_after_display":"94,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-15","filed_date":"2019-04-15","scope":"insider"},{"id":8324097,"accession":"0001144204-19-017010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-017010","line_url":"/filing/0001144204-19-017010#line-2","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":7154.0,"total_display":"7,154.00","total_whole":"7,154","shares_owned_after":93663.0,"shares_owned_after_display":"93,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-29","filed_date":"2019-03-29","scope":"insider"},{"id":8324093,"accession":"0001144204-19-017010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-017010","line_url":"/filing/0001144204-19-017010#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":3066.0,"total_display":"3,066.00","total_whole":"3,066","shares_owned_after":92263.0,"shares_owned_after_display":"92,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-28","filed_date":"2019-03-29","scope":"insider"},{"id":8425281,"accession":"0001144204-19-009857","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-009857","line_url":"/filing/0001144204-19-009857#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.46,"price_display":"5.46","price_state":"stated","total_value":27300.0,"total_display":"27,300.00","total_whole":"27,300","shares_owned_after":91663.0,"shares_owned_after_display":"91,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-25","scope":"insider"},{"id":7954021,"accession":"0001144204-19-005339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-005339","line_url":"/filing/0001144204-19-005339#line-2","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1850.0,"shares_display":"1,850","price_per_share":5.77,"price_display":"5.77","price_state":"stated","total_value":10674.5,"total_display":"10,674.50","total_whole":"10,675","shares_owned_after":86663.0,"shares_owned_after_display":"86,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-06","scope":"insider"},{"id":7954018,"accession":"0001144204-19-005339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-005339","line_url":"/filing/0001144204-19-005339#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":5.91,"price_display":"5.91","price_state":"stated","total_value":41370.0,"total_display":"41,370.00","total_whole":"41,370","shares_owned_after":84813.0,"shares_owned_after_display":"84,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-04","filed_date":"2019-02-06","scope":"insider"},{"id":8263099,"accession":"0001144204-19-004355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-004355","line_url":"/filing/0001144204-19-004355#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":650.0,"shares_display":"650","price_per_share":5.91,"price_display":"5.91","price_state":"stated","total_value":3841.5,"total_display":"3,841.50","total_whole":"3,842","shares_owned_after":77813.0,"shares_owned_after_display":"77,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-30","filed_date":"2019-02-01","scope":"insider"},{"id":8287482,"accession":"0001144204-19-003774","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-003774","line_url":"/filing/0001144204-19-003774#line-2","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8553.0,"shares_display":"8,553","price_per_share":5.91,"price_display":"5.91","price_state":"stated","total_value":50548.23,"total_display":"50,548.23","total_whole":"50,548","shares_owned_after":77163.0,"shares_owned_after_display":"77,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-29","filed_date":"2019-01-30","scope":"insider"},{"id":8287476,"accession":"0001144204-19-003774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-003774","line_url":"/filing/0001144204-19-003774#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1447.0,"shares_display":"1,447","price_per_share":5.84,"price_display":"5.84","price_state":"stated","total_value":8450.48,"total_display":"8,450.48","total_whole":"8,450","shares_owned_after":68610.0,"shares_owned_after_display":"68,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-28","filed_date":"2019-01-30","scope":"insider"},{"id":6095648,"accession":"0001144204-18-063619","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-18-063619","line_url":"/filing/0001144204-18-063619#line-2","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"MUSTANG BIO, INC.","issuer_ticker":"MBIO","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.96,"price_display":"3.96","price_state":"stated","total_value":3960.0,"total_display":"3,960.00","total_whole":"3,960","shares_owned_after":71000.0,"shares_owned_after_display":"71,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-23","filed_date":"2018-12-07","scope":"insider"},{"id":6654619,"accession":"0001144204-18-022402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-022402","line_url":"/filing/0001144204-18-022402#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.8,"price_display":"3.80","price_state":"stated","total_value":3800.0,"total_display":"3,800.00","total_whole":"3,800","shares_owned_after":52500.0,"shares_owned_after_display":"52,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-25","filed_date":"2018-04-25","scope":"insider"},{"id":4897459,"accession":"0001144204-17-052957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-052957","line_url":"/filing/0001144204-17-052957#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":5010.0,"total_display":"5,010.00","total_whole":"5,010","shares_owned_after":51500.0,"shares_owned_after_display":"51,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-17","filed_date":"2017-10-18","scope":"insider"},{"id":4535910,"accession":"0001144204-17-051782","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-051782","line_url":"/filing/0001144204-17-051782#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":5.24,"price_display":"5.24","price_state":"stated","total_value":2620.0,"total_display":"2,620.00","total_whole":"2,620","shares_owned_after":50500.0,"shares_owned_after_display":"50,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-09","filed_date":"2017-10-10","scope":"insider"},{"id":2059945,"accession":"0001094891-16-000489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001094891-16-000489","line_url":"/filing/0001094891-16-000489#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"CB Pharma Acquisition Corp.","issuer_ticker":"CNLM","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-23","scope":"insider"},{"id":2716817,"accession":"0001144204-12-067638","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-067638","line_url":"/filing/0001144204-12-067638#line-1","is_derivative":false,"issuer_cik":"0001001316","issuer_name":"TG THERAPEUTICS, INC.","issuer_ticker":"TGTX","issuer_name_source":null,"issuer_url":"/issuer/0001001316","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":51265.0,"shares_owned_after_display":"51,265","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-06","filed_date":"2012-12-12","scope":"insider"},{"id":7172952,"accession":"0001181431-07-027271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-027271","line_url":"/filing/0001181431-07-027271#line-1","is_derivative":false,"issuer_cik":"0001298246","issuer_name":"Innovive Pharmaceuticals, Inc.","issuer_ticker":"IVPH.OB","issuer_name_source":null,"issuer_url":"/issuer/0001298246","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18315.0,"shares_display":"18,315","price_per_share":2.73,"price_display":"2.73","price_state":"stated","total_value":49999.95,"total_display":"49,999.95","total_whole":"50,000","shares_owned_after":52127.0,"shares_owned_after_display":"52,127","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-24","filed_date":"2007-04-26","scope":"insider"},{"id":8178380,"accession":"0001179110-07-007620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-007620","line_url":"/filing/0001179110-07-007620#line-1","is_derivative":false,"issuer_cik":"0001001316","issuer_name":"MANHATTAN PHARMACEUTICALS INC","issuer_ticker":"MHA","issuer_name_source":null,"issuer_url":"/issuer/0001001316","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55555.0,"shares_display":"55,555","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":49999.5,"total_display":"49,999.50","total_whole":"50,000","shares_owned_after":77288.0,"shares_owned_after_display":"77,288","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-03-30","filed_date":"2007-04-09","scope":"insider"},{"id":5023599,"accession":"0001179110-06-015780","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-06-015780","line_url":"/filing/0001179110-06-015780#line-4","is_derivative":false,"issuer_cik":"0001001316","issuer_name":"MANHATTAN PHARMACEUTICALS INC","issuer_ticker":"MHA","issuer_name_source":null,"issuer_url":"/issuer/0001001316","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.61,"price_display":"0.61","price_state":"stated","total_value":1525.0,"total_display":"1,525.00","total_whole":"1,525","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-07-18","filed_date":"2006-07-31","scope":"insider"},{"id":5023591,"accession":"0001179110-06-015780","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-06-015780","line_url":"/filing/0001179110-06-015780#line-3","is_derivative":false,"issuer_cik":"0001001316","issuer_name":"MANHATTAN PHARMACEUTICALS INC","issuer_ticker":"MHA","issuer_name_source":null,"issuer_url":"/issuer/0001001316","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":1700.0,"total_display":"1,700.00","total_whole":"1,700","shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-07-13","filed_date":"2006-07-31","scope":"insider"},{"id":5023585,"accession":"0001179110-06-015780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-06-015780","line_url":"/filing/0001179110-06-015780#line-2","is_derivative":false,"issuer_cik":"0001001316","issuer_name":"MANHATTAN PHARMACEUTICALS INC","issuer_ticker":"MHA","issuer_name_source":null,"issuer_url":"/issuer/0001001316","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":0.71,"price_display":"0.71","price_state":"stated","total_value":3195.0,"total_display":"3,195.00","total_whole":"3,195","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-07-11","filed_date":"2006-07-31","scope":"insider"},{"id":5023577,"accession":"0001179110-06-015780","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-06-015780","line_url":"/filing/0001179110-06-015780#line-1","is_derivative":false,"issuer_cik":"0001001316","issuer_name":"MANHATTAN PHARMACEUTICALS INC","issuer_ticker":"MHA","issuer_name_source":null,"issuer_url":"/issuer/0001001316","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":0.73,"price_display":"0.73","price_state":"stated","total_value":365.0,"total_display":"365.00","total_whole":"365","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-07-10","filed_date":"2006-07-31","scope":"insider"},{"id":3271123,"accession":"0001179110-06-001340","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-06-001340","line_url":"/filing/0001179110-06-001340#line-2","is_derivative":false,"issuer_cik":"0001001316","issuer_name":"MANHATTAN PHARMACEUTICALS INC","issuer_ticker":"MHA","issuer_name_source":null,"issuer_url":"/issuer/0001001316","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14200.0,"shares_display":"14,200","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":18460.0,"total_display":"18,460.00","total_whole":"18,460","shares_owned_after":21700.0,"shares_owned_after_display":"21,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-01-10","filed_date":"2006-01-12","scope":"insider"},{"id":1552407,"accession":"0001179110-05-008421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-05-008421","line_url":"/filing/0001179110-05-008421#line-1","is_derivative":false,"issuer_cik":"0001001316","issuer_name":"MANHATTAN PHARMACEUTICALS INC","issuer_ticker":"MHTT","issuer_name_source":null,"issuer_url":"/issuer/0001001316","owner_cik":"0001298246","owner_name":"Herskowitz Neil","owner_display_name":"Herskowitz Neil","owner_url":"/insider/0001298246","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.21,"price_display":"1.21","price_state":"stated","total_value":6050.0,"total_display":"6,050.00","total_whole":"6,050","shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-04-27","filed_date":"2005-04-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":28,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001680048","name":"MUSTANG BIO, INC.","url":"/issuer/0001680048","role":"Director","n_filings":2,"first_seen":"2018-12-07","last_seen":"2025-12-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001644963","name":"AVENUE THERAPEUTICS, INC.","url":"/issuer/0001644963","role":"Director","n_filings":14,"first_seen":"2017-10-10","last_seen":"2024-12-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001619551","name":"CB Pharma Acquisition Corp.","url":"/issuer/0001619551","role":"Director","n_filings":1,"first_seen":"2016-05-23","last_seen":"2016-05-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001001316","name":"TG THERAPEUTICS, INC.","url":"/issuer/0001001316","role":"Director","n_filings":5,"first_seen":"2005-04-28","last_seen":"2012-12-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001337223","name":"Innovive Pharmaceuticals, Inc.","url":"/issuer/0001337223","role":"Director","n_filings":1,"first_seen":"2007-04-26","last_seen":"2007-04-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001298246","retrieved_at":"2026-08-22T11:57:49+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}